135 related articles for article (PubMed ID: 35961871)
1. Re: Artificial Intelligence for Diagnosis and Gleason Grading of Prostate Cancer: The PANDA Challenge.
Dasgupta P
Eur Urol; 2022 Nov; 82(5):571. PubMed ID: 35961871
[No Abstract] [Full Text] [Related]
2. Artificial Intelligence for Diagnosis and Gleason Grading of Prostate Cancer in Biopsies-Current Status and Next Steps.
Kartasalo K; Bulten W; Delahunt B; Chen PC; Pinckaers H; Olsson H; Ji X; Mulliqi N; Samaratunga H; Tsuzuki T; Lindberg J; Rantalainen M; Wählby C; Litjens G; Ruusuvuori P; Egevad L; Eklund M
Eur Urol Focus; 2021 Jul; 7(4):687-691. PubMed ID: 34393083
[TBL] [Abstract][Full Text] [Related]
3. Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge.
Bulten W; Kartasalo K; Chen PC; Ström P; Pinckaers H; Nagpal K; Cai Y; Steiner DF; van Boven H; Vink R; Hulsbergen-van de Kaa C; van der Laak J; Amin MB; Evans AJ; van der Kwast T; Allan R; Humphrey PA; Grönberg H; Samaratunga H; Delahunt B; Tsuzuki T; Häkkinen T; Egevad L; Demkin M; Dane S; Tan F; Valkonen M; Corrado GS; Peng L; Mermel CH; Ruusuvuori P; Litjens G; Eklund M;
Nat Med; 2022 Jan; 28(1):154-163. PubMed ID: 35027755
[TBL] [Abstract][Full Text] [Related]
4. An Artificial Intelligence-based Support Tool for Automation and Standardisation of Gleason Grading in Prostate Biopsies.
Marginean F; Arvidsson I; Simoulis A; Christian Overgaard N; Åström K; Heyden A; Bjartell A; Krzyzanowska A
Eur Urol Focus; 2021 Sep; 7(5):995-1001. PubMed ID: 33303404
[TBL] [Abstract][Full Text] [Related]
5. Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study.
Ström P; Kartasalo K; Olsson H; Solorzano L; Delahunt B; Berney DM; Bostwick DG; Evans AJ; Grignon DJ; Humphrey PA; Iczkowski KA; Kench JG; Kristiansen G; van der Kwast TH; Leite KRM; McKenney JK; Oxley J; Pan CC; Samaratunga H; Srigley JR; Takahashi H; Tsuzuki T; Varma M; Zhou M; Lindberg J; Lindskog C; Ruusuvuori P; Wählby C; Grönberg H; Rantalainen M; Egevad L; Eklund M
Lancet Oncol; 2020 Feb; 21(2):222-232. PubMed ID: 31926806
[TBL] [Abstract][Full Text] [Related]
6. Automated systems comparable to expert pathologists for prostate cancer Gleason grading.
Thomas T
Nat Rev Urol; 2020 Mar; 17(3):131. PubMed ID: 32055009
[No Abstract] [Full Text] [Related]
7. Development and Validation of a Deep Learning Algorithm for Gleason Grading of Prostate Cancer From Biopsy Specimens.
Nagpal K; Foote D; Tan F; Liu Y; Chen PC; Steiner DF; Manoj N; Olson N; Smith JL; Mohtashamian A; Peterson B; Amin MB; Evans AJ; Sweet JW; Cheung C; van der Kwast T; Sangoi AR; Zhou M; Allan R; Humphrey PA; Hipp JD; Gadepalli K; Corrado GS; Peng LH; Stumpe MC; Mermel CH
JAMA Oncol; 2020 Sep; 6(9):1372-1380. PubMed ID: 32701148
[TBL] [Abstract][Full Text] [Related]
8. Artificial intelligence in prostate histopathology: where are we in 2021?
Oszwald A; Wasinger G; Pradere B; Shariat SF; Compérat EM
Curr Opin Urol; 2021 Jul; 31(4):430-435. PubMed ID: 33965977
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Use of Combined Artificial Intelligence and Pathologist Assessment to Review and Grade Prostate Biopsies.
Steiner DF; Nagpal K; Sayres R; Foote DJ; Wedin BD; Pearce A; Cai CJ; Winter SR; Symonds M; Yatziv L; Kapishnikov A; Brown T; Flament-Auvigne I; Tan F; Stumpe MC; Jiang PP; Liu Y; Chen PC; Corrado GS; Terry M; Mermel CH
JAMA Netw Open; 2020 Nov; 3(11):e2023267. PubMed ID: 33180129
[TBL] [Abstract][Full Text] [Related]
10. An artificial intelligence algorithm for prostate cancer diagnosis in whole slide images of core needle biopsies: a blinded clinical validation and deployment study.
Pantanowitz L; Quiroga-Garza GM; Bien L; Heled R; Laifenfeld D; Linhart C; Sandbank J; Albrecht Shach A; Shalev V; Vecsler M; Michelow P; Hazelhurst S; Dhir R
Lancet Digit Health; 2020 Aug; 2(8):e407-e416. PubMed ID: 33328045
[TBL] [Abstract][Full Text] [Related]
11. Identification of areas of grading difficulties in prostate cancer and comparison with artificial intelligence assisted grading.
Egevad L; Swanberg D; Delahunt B; Ström P; Kartasalo K; Olsson H; Berney DM; Bostwick DG; Evans AJ; Humphrey PA; Iczkowski KA; Kench JG; Kristiansen G; Leite KRM; McKenney JK; Oxley J; Pan CC; Samaratunga H; Srigley JR; Takahashi H; Tsuzuki T; van der Kwast T; Varma M; Zhou M; Clements M; Eklund M
Virchows Arch; 2020 Dec; 477(6):777-786. PubMed ID: 32542445
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of an Artificial Intelligence-Powered Platform for Prostate Cancer Grading and Quantification.
Huang W; Randhawa R; Jain P; Iczkowski KA; Hu R; Hubbard S; Eickhoff J; Basu H; Roy R
JAMA Netw Open; 2021 Nov; 4(11):e2132554. PubMed ID: 34730818
[TBL] [Abstract][Full Text] [Related]
13. The utility of artificial intelligence in the assessment of prostate pathology.
Egevad L; Ström P; Kartasalo K; Olsson H; Samaratunga H; Delahunt B; Eklund M
Histopathology; 2020 May; 76(6):790-792. PubMed ID: 32402150
[No Abstract] [Full Text] [Related]
14. Re: Artificial Intelligence for Diagnosis and Grading of Prostate Cancer in Biopsies: A Population-Based, Diagnostic Study.
Taneja SS
J Urol; 2020 Sep; 204(3):620-621. PubMed ID: 32586169
[No Abstract] [Full Text] [Related]
15. Re: Artificial Intelligence for Diagnosis and Grading of Prostate Cancer in Biopsies: A Population-based, Diagnostic Study.
Zlotta AR; Sadeghian A
Eur Urol; 2020 Aug; 78(2):290-291. PubMed ID: 32389441
[No Abstract] [Full Text] [Related]
16. Artificial Intelligence-assisted Prostate Cancer Diagnosis: Radiologic-Pathologic Correlation.
Mata LA; Retamero JA; Gupta RT; García Figueras R; Luna A
Radiographics; 2021 Oct; 41(6):1676-1697. PubMed ID: 34597215
[TBL] [Abstract][Full Text] [Related]
17. Outcome of Gleason 3 + 5 = 8 Prostate Cancer Diagnosed on Needle Biopsy: Prognostic Comparison with Gleason 4 + 4 = 8.
Harding-Jackson N; Kryvenko ON; Whittington EE; Eastwood DC; Tjionas GA; Jorda M; Iczkowski KA
J Urol; 2016 Oct; 196(4):1076-81. PubMed ID: 27265220
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in prostate cancer pathology: Gleason grading and beyond.
Shah RB; Zhou M
Pathol Int; 2016 May; 66(5):260-72. PubMed ID: 26991008
[TBL] [Abstract][Full Text] [Related]
19. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.
Epstein JI; Egevad L; Amin MB; Delahunt B; Srigley JR; Humphrey PA;
Am J Surg Pathol; 2016 Feb; 40(2):244-52. PubMed ID: 26492179
[TBL] [Abstract][Full Text] [Related]
20. Gleason score 5 + 3 = 8 (grade group 4) prostate cancer-a rare occurrence with contemporary grading.
Kryvenko ON; Williamson SR; Schwartz LE; Epstein JI
Hum Pathol; 2020 Mar; 97():40-51. PubMed ID: 31923450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
